DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $976,480 | +3.3% | 3,679 | +0.5% | 0.12% | -6.5% |
| Q3 2022 | $945,000 | -1.2% | 3,660 | -2.9% | 0.12% | +1.7% |
| Q2 2022 | $956,000 | -23.6% | 3,770 | -11.6% | 0.12% | -6.2% |
| Q1 2022 | $1,251,000 | -14.1% | 4,263 | -3.7% | 0.13% | -6.5% |
| Q4 2021 | $1,457,000 | +8.3% | 4,428 | +0.2% | 0.14% | -2.1% |
| Q3 2021 | $1,345,000 | +14.6% | 4,419 | +1.0% | 0.14% | +17.5% |
| Q2 2021 | $1,174,000 | +14.9% | 4,375 | -3.6% | 0.12% | +4.3% |
| Q1 2021 | $1,022,000 | -4.3% | 4,538 | -5.6% | 0.12% | -8.0% |
| Q4 2020 | $1,068,000 | +1.4% | 4,806 | -1.7% | 0.12% | -11.3% |
| Q3 2020 | $1,053,000 | +8.0% | 4,890 | -11.3% | 0.14% | +6.8% |
| Q2 2020 | $975,000 | +5.1% | 5,515 | -17.7% | 0.13% | -8.3% |
| Q1 2020 | $928,000 | -22.7% | 6,705 | -14.2% | 0.14% | +2.1% |
| Q4 2019 | $1,200,000 | +1.8% | 7,816 | -4.3% | 0.14% | -0.7% |
| Q3 2019 | $1,179,000 | -0.5% | 8,166 | -1.5% | 0.14% | +2.2% |
| Q2 2019 | $1,185,000 | +3.5% | 8,290 | -4.4% | 0.14% | +3.7% |
| Q1 2019 | $1,145,000 | +18.9% | 8,673 | -7.1% | 0.13% | +15.5% |
| Q4 2018 | $963,000 | -12.7% | 9,334 | -8.0% | 0.12% | -10.1% |
| Q3 2018 | $1,103,000 | +6.8% | 10,149 | -3.1% | 0.13% | +1.6% |
| Q2 2018 | $1,033,000 | -1.8% | 10,469 | -2.5% | 0.13% | -3.8% |
| Q1 2018 | $1,052,000 | +4.8% | 10,737 | -0.8% | 0.13% | +4.8% |
| Q4 2017 | $1,004,000 | +2.4% | 10,823 | -5.2% | 0.13% | +1.6% |
| Q3 2017 | $980,000 | -2.8% | 11,419 | -4.4% | 0.12% | -4.6% |
| Q2 2017 | $1,008,000 | +6.0% | 11,949 | +7.4% | 0.13% | +8.3% |
| Q1 2017 | $951,000 | +2.4% | 11,128 | -6.7% | 0.12% | -7.0% |
| Q4 2016 | $929,000 | -20.7% | 11,924 | -20.2% | 0.13% | -20.4% |
| Q3 2016 | $1,171,000 | -37.1% | 14,941 | -18.9% | 0.16% | -38.9% |
| Q2 2016 | $1,861,000 | -56.8% | 18,425 | -59.4% | 0.26% | -55.5% |
| Q1 2016 | $4,309,000 | -6.2% | 45,422 | -8.1% | 0.60% | -6.7% |
| Q4 2015 | $4,592,000 | +2.3% | 49,438 | -6.1% | 0.64% | -10.9% |
| Q3 2015 | $4,489,000 | -25.9% | 52,676 | -25.6% | 0.72% | -17.2% |
| Q2 2015 | $6,060,000 | +19.0% | 70,806 | +18.1% | 0.86% | +20.8% |
| Q1 2015 | $5,092,000 | +0.6% | 59,969 | +1.6% | 0.72% | -3.1% |
| Q4 2014 | $5,061,000 | +18.7% | 59,049 | +5.2% | 0.74% | +2.1% |
| Q3 2014 | $4,265,000 | -2.4% | 56,128 | +1.1% | 0.72% | +6.3% |
| Q2 2014 | $4,371,000 | +7.4% | 55,514 | +2.4% | 0.68% | +1.6% |
| Q1 2014 | $4,068,000 | -4.3% | 54,238 | -1.5% | 0.67% | -0.6% |
| Q4 2013 | $4,251,000 | -45.1% | 55,064 | -52.9% | 0.67% | -5.7% |
| Q3 2013 | $7,738,000 | +102.7% | 116,864 | +93.8% | 0.72% | -0.3% |
| Q2 2013 | $3,817,000 | – | 60,301 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |